217 related articles for article (PubMed ID: 12404241)
21. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
[TBL] [Abstract][Full Text] [Related]
22. Oxidative-stress-related changes in the livers of bile-duct-ligated rats.
Huang YT; Hsu YC; Chen CJ; Liu CT; Wei YH
J Biomed Sci; 2003; 10(2):170-8. PubMed ID: 12595753
[TBL] [Abstract][Full Text] [Related]
23. Expression and localization of the renin-angiotensin system in the rat pancreas.
Leung PS; Chan WP; Wong TP; Sernia C
J Endocrinol; 1999 Jan; 160(1):13-9. PubMed ID: 9854172
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
25. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.
Jonsson JR; Clouston AD; Ando Y; Kelemen LI; Horn MJ; Adamson MD; Purdie DM; Powell EE
Gastroenterology; 2001 Jul; 121(1):148-55. PubMed ID: 11438504
[TBL] [Abstract][Full Text] [Related]
27. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
28. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
[TBL] [Abstract][Full Text] [Related]
29. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat.
Zimmermann H; Fellay M; Zimmermann A
J Hepatol; 1997 Jan; 26(1):158-66. PubMed ID: 9148007
[TBL] [Abstract][Full Text] [Related]
30. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.
Yang L; Bataller R; Dulyx J; Coffman TM; Ginès P; Rippe RA; Brenner DA
J Hepatol; 2005 Aug; 43(2):317-23. PubMed ID: 15964094
[TBL] [Abstract][Full Text] [Related]
31. A contradictory role of A1 adenosine receptor in carbon tetrachloride- and bile duct ligation-induced liver fibrosis in mice.
Yang P; Han Z; Chen P; Zhu L; Wang S; Hua Z; Zhang J
J Pharmacol Exp Ther; 2010 Mar; 332(3):747-54. PubMed ID: 20007753
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
33. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
34. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
Huang Q; Guo Y; Zeng H; Xie W; Yan H; Ding H
Endocr Res; 2011; 36(3):93-100. PubMed ID: 21314328
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of glomerular AT1 receptors in rats with myocardial infarction.
Mento PF; Pica ME; Hilepo J; Chang J; Hirsch L; Wilkes BM
Am J Physiol; 1998 Oct; 275(4):H1247-53. PubMed ID: 9746472
[TBL] [Abstract][Full Text] [Related]
36. Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.
Türkay C; Yönem O; Arici S; Koyuncu A; Kanbay M
Dig Dis Sci; 2008 Mar; 53(3):789-93. PubMed ID: 17763951
[TBL] [Abstract][Full Text] [Related]
37. Induction of arginase II in livers of bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Mori M; Gotoh T; Khoo HE
Biochem Pharmacol; 2002 Mar; 63(6):1043-50. PubMed ID: 11931836
[TBL] [Abstract][Full Text] [Related]
38. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis.
Tsang SW; Cheng CH; Leung PS
Regul Pept; 2004 Jul; 119(3):213-9. PubMed ID: 15120483
[TBL] [Abstract][Full Text] [Related]
39. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
40. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
